SCHEMBL3484192

SCHEMBL3484192

CCOC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(CBr)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.59
ABCB11 O95342 2/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
TSHR P16473 2/20 0.59
HTR2A P28223 2/20 0.59
PMP22 Q01453 2/20 0.59
PPARG P37231 10/20 0.52
FBP1 P09467 6/20 0.49
OPRK1 P41145 1/20 0.48
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ADRB3 P13945 1/20 0.47
HPGD P15428 1/20 0.47
CNR1 P21554 1/20 0.47
ACHE P22303 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3900554 0.93 PPARA (0.68) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3484747 0.89 PPARA (0.62) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3483913 0.89 PPARA (0.62) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3484510 0.88 PPARG (0.54) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3483995 0.86 PPARA (0.66) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL12573936 0.83 PPARA (0.86) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3484043 0.82 PPARA (0.48) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL1349983 0.82 PPARA (0.64) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL8924845 0.82 PPARA (0.64) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL13763797 0.81 PPARA (0.71) PPARAABCB11CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 PPARA 1045/4885ABCB11 402/4885CYP1A2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.